IceCure Medical (ICCM) Income from Continuing Operations (2025 - 2026)

IceCure Medical (ICCM) reported Income from Continuing Operations of 4247000.0 for Q1 2026, up 16.13% year-over-year from 3657000.0 in Q1 2025, and up 16.13% on a QoQ basis from 3657000.0 in Q1 2025.

IceCure Medical (ICCM) has 2 years of Income from Continuing Operations data on file, last reported at 4247000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 4.25 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.25 Mn
Mar 31, 2025 3.66 Mn